Visual Snow Syndrome

Deep Research Summary: Visual Snow Syndrome

Manual MONDO:0018486

Deep Research Summary: Visual Snow Syndrome

Research Method

Manual literature search conducted via PubMed and web search on 2026-01-11. Deep research APIs (falcon, openai, perplexity) were unavailable due to API errors.

Key References Identified

Foundational Studies

  1. PMID:24645145 - Schankin CJ et al. (2014) Brain
  2. "'Visual snow' - a disorder distinct from persistent migraine aura"
  3. Foundational study characterizing VSS phenotype in 120 patients
  4. Established visual snow as distinct from migraine aura

  5. PMID:29934719 - Metzler AI, Robertson CE (2018) Curr Neurol Neurosci Rep

  6. "Visual Snow Syndrome: Proposed Criteria, Clinical Implications, and Pathophysiology"
  7. Proposed diagnostic criteria for VSS

  8. PMID:31941797 - Puledda F et al. (2020) Neurology

  9. "Visual snow syndrome: A clinical and phenotypical description of 1,100 cases"
  10. Largest cohort study to date validating diagnostic criteria

Pathophysiology

  1. PMID:24816400 - Schankin CJ et al. (2014) Headache
  2. "The relation between migraine, typical migraine aura and 'visual snow'"
  3. PET imaging showing hypermetabolism in lingual gyrus
  4. Demonstrates comorbid migraine aggravates VSS symptoms

  5. PMID:34570907 - Klein A, Schankin CJ (2021) Headache

  6. "Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor"
  7. Proposes VSS as part of spectrum of perceptual disorders with shared pathophysiology

  8. PMID:33008511 - Eren O, Schankin CJ (2020) Prog Brain Res

  9. "Insights into pathophysiology and treatment of visual snow syndrome: A systematic review"
  10. Systematic review of pathophysiology and treatment evidence

  11. PMID:38465699 - Aeschlimann SA et al. (2024) Curr Opin Neurol

  12. "Visual snow syndrome: recent advances in understanding the pathophysiology and potential treatment approaches"
  13. Most recent review on pathophysiology showing VSS as network disorder

Treatment Studies

  1. PMID:31213497 - van Dongen RM et al. (2019) Neurology
  2. "Treatment effects and comorbid diseases in 58 patients with visual snow"
  3. Class IV evidence for lamotrigine (19.2% partial response)

  4. PMID:28349350 - Bou Ghannam A, Pelak VS (2017) Curr Treat Options Neurol

  5. "Visual Snow: a Potential Cortical Hyperexcitability Syndrome"
  6. Treatment recommendations including lamotrigine protocol

  7. PMID:40129600 - Ayesha A et al. (2025) Eye Brain

    • "Diagnostic and Management Strategies of Visual Snow Syndrome: Current Perspectives"
    • Most recent treatment review showing benzodiazepines (71.4%) and lamotrigine (61.5%) effectiveness

Comorbidities

  1. PMID:28723606 - Renze M (2017) Int Tinnitus J

    • "Visual Snow Syndrome and Its Relationship to Tinnitus"
    • 63% of VSS patients have bilateral tinnitus
  2. PMID:31714263 - Traber GL et al. (2020) Curr Opin Neurol

    • "Visual snow syndrome: a review on diagnosis, pathophysiology, and treatment"
    • Overview of visual cortex hyperexcitability hypothesis

Key Findings Summary

Epidemiology

  • Affects approximately 2% of UK population
  • No sex prevalence
  • Average age 29 years
  • ~40% have symptoms since childhood

Core Symptoms (Diagnostic Criteria)

  1. Visual snow (TV static-like flickering dots) - required
  2. Plus ≥2 of: palinopsia, photopsia, photophobia, nyctalopia

Additional Common Symptoms

  • Entoptic phenomena (floaters, BFEP, self-light)
  • Tinnitus (52-63%)
  • Migraine comorbidity (59%)
  • Anxiety/depression (40-45%)

Pathophysiology

  • Visual cortex hyperexcitability (lingual gyrus hypermetabolism)
  • Impaired inhibitory feedback mechanisms
  • Thalamocortical network dysfunction
  • Possible glutamatergic/serotonergic involvement

Treatment Options

  • Lamotrigine: Best pharmacological evidence (20-60% partial response)
  • Benzodiazepines: Highest response rate (71%) but long-term concerns
  • Tinted lenses: FL-41 filters provide consistent relief
  • CBT/Mindfulness: Emerging nonpharmacological option
  • No complete cures reported